Product logins

Find logins to all Clarivate products below.


Competitive intelligence

Never miss a beat across your entire competitive landscape

Keep track of your complete competitive environment

Stay ahead of competition in your therapy area with critical insights into drug pipeline and probability of success, generics and biosimilars coverage, digital health therapies and partnerships.

Monitor early-stage developments

Develop a long-term competitive advantage by identifying early signs of competitor movements with insights into their discovery and preclinical stage assets and patent activity.

Obtain broad and deep intel

Access global competitive intel across thousands of indications, including rare and niche.

Maximize or defend your market share

Optimize or protect your slice of the market by monitoring loss of brand exclusivity, and sizing threats and opportunities in the generics and biosimilars space.

Anticipate your competitor’s next move

Explore partnerships being made in your space and understand how digital health is transforming your therapy area of interest.

Confidently monitor your area of interest

Cortellis Competitive Intelligence

Make critical portfolio decisions backed by comprehensive pipeline and pharma competitive intelligence

Cortellis Product Intelligence

Grow your business and build robust supply chains

Cortellis Digital Health Intelligence

Understand the digital health ecosystem

Cortellis Clinical Trials Intelligence

Position your clinical trials for success from day one

Biosimilars

Size opportunities and threats in this lucrative market

BioWorld

Actionable intelligence on the most innovative therapeutics and medical technologies in development

Monitor your entire competitive landscape

Get in touch

Clarivate has helped Neuland accelerate business growth in the CRAMS [Contract research and manufacturing services] segment and helped us [make] strategic decisions in product expansion.

Mr. Sajeev Emmanuel Medikonda, Head of Corporate Planning and Strategy, Neuland

Through Cortellis we have the most reliable and updated source of drug intelligence to drive our Marketing and Business Development strategic choices.

Massimo Orlando Department Head, Alfasigma SPA

We have had [Cortellis Generics Intelligence] for over 15 years. With competition at an all time high you need a place with direct information in one spot - PIV litigation, API, sales data, etc. This makes a great starting point for product selection.

Business Development and Licensing professional Par Pharmaceutical Companies, Inc., USA

chevron_left
chevron_right

93k+
pipeline drugs and biologics, including 30k+ early-stage
283k+
company profiles
3k+
indications covered, including rare diseases
6m+
patents

Resources

Drugs to Watch 2025 Drugs to Watch 2025
Report
Drugs to Watch 2025

Drugs to Watch 2025 - a new generation of breakthrough treatments making their way to market and bringing hope to patients

The AMJEVITA impact: Innovative U.S. biosimilar pricing models The AMJEVITA impact: Innovative U.S. biosimilar pricing models
Blog July 5, 2023
The AMJEVITA impact: Innovative U.S. biosimilar pricing models

The month of July could see seven FDA-approved adalimumab biosimilars launch in the United States, an unprecedented situation for a market that has been relatively slow to embrace biosimilars. By…

Explore Advanced Insights with Cortellis Generics Intelligence Explore Advanced Insights with Cortellis Generics Intelligence
Webinar
Explore Advanced Insights with Cortellis Generics Intelligence

   

chevron_left
chevron_right